Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
very engaged, close to the employees
Was ist das Beste an Ihrem Vergütungspaket?
annual bonus is fairly distributed
Was sind einige der besten Dinge an Ihrem Team?
team members are knowledgeable and we help each other
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
the thinking and all the activities are for the patients
Was macht Sie bei der Arbeit am glücklichsten?
I have got the opportunity to be involved in the development of the drug until market approval
Other Employee Reviews for Karyopharm Therapeutics
×